FN2 Earnings Intelligence

TG Therapeutics, Inc. ratios

TG Therapeutics, Inc. (TGTX) Ratios (annual) derived from persisted SEC financial facts.

Ratios

USD in millions, except per-share values and percentages.

Metric 12/31/202112/31/202212/31/202312/31/202412/31/2025
Revenue Growth 4,300.7%-58.4%8,290.0%40.8%87.3%
Gross Margin --94.0%88.3%83.7%
EBITDA Margin -5,150.1%-6,913.3%8.9%12.8%20.0%
Net Margin -5,204.1%-7,121.5%5.4%7.1%72.6%
FCF Margin -4,425.7%-6,326.2%-13.4%-12.3%-4.1%
Diluted EPS Growth --106.2%66.7%1,746.7%

Get the TGTX recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.